https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/clinical-trial-investigate-treatment-acute-lymphoblastic-leukaemia-open-gosh/
Clinical trial to investigate treatment of acute lymphoblastic leukaemia to open at GOSH
28 Jun 2016, 2:12 p.m.
A Phase I clinical trial (CARPALL) has opened at Great Ormond Street Hospital (GOSH) to investigate the use of immunotherapy with genetically modified T cells for acute lymphoblastic leukemia (ALL). The trial is led by Professor Persis Amrolia, who is supported by the NIHR Great Ormond Street BRC.
Relapse is the primary cause of treatment failure for paediatric ALL with 25 children in the UK dying per year from untreatable leukaemia relapse. Emerging data shows unprecedented responses to immunotherapy, with genetically redirected T cells expressing second-generation chimeric antigen receptors (CARs) enabling them to recognise and kill ALL cells. However, it is unclear how sustained these remissions are, as most responding patients have been consolidated with stem cell transplant (SCT).
The trial will take place at GOSH, University College London Hospital (UCLH) and Manchester Children’s hospital. It aims to treat 15 children and young adults with high-risk relapsed ALL to investigate the durability of responses to CD19CAR T cells, and whether this strategy could remove the need for SCT. If successful, it could mean that the short term mortality and late toxicities of SCT could be avoided.
New study pinpoints why some transplanted kidneys are rejected
Researchers at University College London (UCL), the Wellcome Sanger Institute and the University of Cambridge combined technology that determines the genetic or RNA sequence of individual cells with powerful 3D imaging to look at lymphatic vessels
Scientists discover clues to help children with rare muscle disease
New ground-breaking research by experts at Great Ormond Street Hospital (GOSH) and University College London (UCL) has led to an exciting discovery that could help children with the rare muscle disease, juvenile dermatomyositis (JDM).
What do bush babies, tamarin monkeys, and mouse lemurs have that humans don’t?
GOSH imaging researchers have worked with teams in Harvard in the USA to work out how and when our pelvises developed to be different from other animals.
Nanodiamonds and hormones used in rare condition to promote lung growth
An international research team led by GOSH, UCL and KU Leuven in Belgium, is using 3D-printing and nanodiamonds, to design treatments that could help babies repair their damaged lungs in the womb.